Novel Prenatal Diagnostics and Their Impact in Asian Countries
Foundation for Genomics and Population Health/Humanitarian Centre
Hughes Hall, University of Cambridge, Mortimer Road, Cambridge CB1 2EW, UK
8 March 2012 - 4.30pm-7pm
A discussion of noninvasive prenatal diagnosis and what it means for Asia and the developing world, introduced by Alison Hall (Senior Policy Adviser at the Foundation for Genomics and Population Health and a contributor to the book Altruism Reconsidered: Exploring New Approaches to Property in Human Tissue) and Dr Margaret Sleeboom-Faulkner (Reader in Anthropology at the University of Sussex and editor of the book Frameworks of Choice: Predictive and Genetic Testing in Asia). The event will mark International Women's Day, and also forms part of the Humanitarian Centre's Global Health Year.
Novel noninvasive prenatal tests using a blood sample from the mother can be used to determine the sex and health of the growing baby from as early as seven weeks gestation. These tests have profound implications for the choices available to women at early stages of pregnancy, and are likely to be adopted on a global basis. But their implications for the developing world, particularly Asia, have been largely unexplored.
Attendance is free but advance booking is required. To register, use this online form or contact Jane Lane at or on +44 (0)1223 740 200.
Buy Altruism Reconsidered: Exploring New Approaches to Property in Human Tissue, coauthored by Alison Hall, from Amazon UK or Amazon USA; and buy Frameworks of Choice: Predictive and Genetic Testing in Asia, edited by Dr Margaret Sleeboom-Faulkner, from Amazon UK or Amazon USA.